TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2866932

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Amiloride (5 mg) with Hydrochlorothiazide (50 mg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined therapy (Atenolol + Amiloride + Hydrochlorothiazide)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Beta-blocker
Number of subjects: 26

Group type: COMPARATOR
Intervention: Diuretic
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Diuretic treatment alone or in combination
Number of subjects: 26
Study: 31075767

Group type: EXPERIMENTAL
Intervention: Incisional vacuum-assisted closure (VAC)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard wound dressings (control)
Number of subjects: 64
Study: 30347072

Group type: EXPERIMENTAL
Intervention: CHX 2% mouthwash
Number of subjects: 8665

Group type: EXPERIMENTAL
Intervention: SOD (mouthpaste with colistin, tobramycin, and nystatin)
Number of subjects: 8665

Group type: EXPERIMENTAL
Intervention: SDD (mouthpaste and gastrointestinal suspension with the same antibiotics)
Number of subjects: 8665

Group type: COMPARATOR
Intervention: Standard care (baseline period)
Number of subjects: 8665
Study: 26864367

Group type: EXPERIMENTAL
Intervention: Micronutrient powders (MNPs) marketed in intervention villages
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Control group (no MNPs marketed)
Number of subjects: 1062
Study: 25171966

Group type: EXPERIMENTAL
Intervention: Cre8 DES
Number of subjects: 38

Group type: COMPARATOR
Intervention: Vision/Multilink8 BMS
Number of subjects: 38
Study: 22539545

Group type: EXPERIMENTAL
Intervention: Cilostazol treatment
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Baseline and 7 months follow-up
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Apolipoprotein B/A-I levels
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Apolipoprotein B/A-I at 7 months
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Remnant lipoprotein cholesterol levels
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: High-density lipoprotein cholesterol elevation
Number of subjects: 230
Study: 20146685

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary interventions (PCI) with drug eluting stents (DES)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coronary bypass surgery
Number of subjects: 0
Study: 17617802

Group type: EXPERIMENTAL
Intervention: Light bandage (25 patients)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bulky dressing with a volar splint (25 patients)
Number of subjects: 50
Study: 15995768

Group type: EXPERIMENTAL
Intervention: Extraoral cervical traction headgear
Number of subjects: 26
Study: 17118822

Group type: EXPERIMENTAL
Intervention: Postconditioning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ischemic-reperfusion (IR) group
Number of subjects: 0
Study: 10365577

Group type: EXPERIMENTAL
Intervention: Sultamicillin (4 days orally)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (4 days orally)
Number of subjects: 85
Study: 8681927

Group type: EXPERIMENTAL
Intervention: Group H (4-5 sets of 15-20 RM with sufficient rest between sets)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Group S (8-9 sets of 4-6 RM with 90 s of rest between sets)
Number of subjects: 11
Study: 1994402

Group type: EXPERIMENTAL
Intervention: High-dose urokinase (250,000 U/h for 4 hours and then 125,000 U/h)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Low-dose urokinase (50,000 U/h)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: High-dose urokinase
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Low-dose urokinase
Number of subjects: 63
Study: 6614537

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) with respiratory frequency maintained at 100/min and I/E ratios of 0.25, 0.43, and 0.67 (Group A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) with I/E ratio maintained at 0.43 and varying respiratory frequencies (Group B)
Number of subjects: 24
Study: 31498250

Group type: EXPERIMENTAL
Intervention: Sensor system for early illness recognition
Number of subjects: 55
Study: 28849895

Group type: EXPERIMENTAL
Intervention: Subgroup-specific pain rehabilitation program based on the Multidimensional Pain Inventory (MPI) Classification System
Number of subjects: 139

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 139
Study: 25828951

Group type: EXPERIMENTAL
Intervention: Three narrow diameter implants placed using osteotomes with a one-stage procedure and 12-week loading.
Number of subjects: 40
Study: 24503174

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24IU)
Number of subjects: 58
Study: 22906283

Group type: EXPERIMENTAL
Intervention: 3% chloroprocaine with adrenaline (group CA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3% chloroprocaine (group C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with adrenaline (group LA)
Number of subjects: 60
Study: 20106646

Group type: EXPERIMENTAL
Intervention: EPA/DHA (3.4 g/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin (650 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study: 17295758

Group type: EXPERIMENTAL
Intervention: Prokinetic agents (metoclopramide, domperidone, trimebutine, cisapride, itopride, mosapride)
Number of subjects: 1844

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1844
Study: 16086935

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU) and Vitamin C (1000 mg) daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg) only
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 100
Study: 12065207

Group type: EXPERIMENTAL
Intervention: High-dose candesartan (16 mg)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Low-dose candesartan (8 mg)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standardised medication
Number of subjects: 116
Study: 10049410

Group type: EXPERIMENTAL
Intervention: Transoral endoscopy
Number of subjects: 170

Group type: COMPARATOR
Intervention: Transnasal endoscopy
Number of subjects: 170

Group type: COMPARATOR
Intervention: Videoendoscope (larger diameter)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Fiberoptic endoscope (smaller diameter)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Endoscope insertion by oral route
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Patient tolerance
Number of subjects: 170
Study: 8786163

Group type: EXPERIMENTAL
Intervention: Phyllanthus amarus preparation for 10 days
Number of subjects: 9
Study: 31036091

Group type: EXPERIMENTAL
Intervention: Cognitively‐Based Compassion Training (CBCT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cancer health education (CHE)
Number of subjects: 40
Study: 28276566

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 8240

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 8240

Group type: EXPERIMENTAL
Intervention: Overall population (low risk)
Number of subjects: 8240

Group type: EXPERIMENTAL
Intervention: Overall population (high risk)
Number of subjects: 8240

Group type: COMPARATOR
Intervention: Warfarin (high risk)
Number of subjects: 8240

Group type: EXPERIMENTAL
Intervention: Edoxaban (high risk)
Number of subjects: 8240
Study: 25964594

Group type: EXPERIMENTAL
Intervention: 3D conformal radiotherapy (3DCRT) with hormonal therapy (HT) administered in 92% of patients
Number of subjects: 97
Study: 23663336

Group type: EXPERIMENTAL
Intervention: Imatinib (n = 23)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (n = 12)
Number of subjects: 35
Study: 21900148

Group type: EXPERIMENTAL
Intervention: Low-glycemic index diet (LGI)
Number of subjects: 99

Group type: COMPARATOR
Intervention: High-fiber moderate-GI diet (HF)
Number of subjects: 99
Study: 18569470

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol
Number of subjects: 57

Group type: COMPARATOR
Intervention: Vaginal prostaglandin E2 (Prostin)
Number of subjects: 57
Study: 16059533

Group type: EXPERIMENTAL
Intervention: Dressing with sterile gauze (EG 1)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Dressing with sterile transparent film (EG 2)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Hypoallergenic adhesive tape (CG)
Number of subjects: 68
Study: 12066725

Group type: EXPERIMENTAL
Intervention: Sevoflurane/nitrous oxide anaesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Propofol i.v. anaesthesia
Number of subjects: 20
Study: 10581657

Group type: EXPERIMENTAL
Intervention: FP 4 mg
Number of subjects: 301

Group type: COMPARATOR
Intervention: FP 1 mg
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 8694380

Group type: EXPERIMENTAL
Intervention: Halothane induction/halothane maintenance (group H/H)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Propofol induction and maintenance (group P/P)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Halothane induction/propofol maintenance (group H/P)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Propofol induction/halothane maintenance (group P/H)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups (nitrous oxide and oxygen administered)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vomiting within the first 6 h
Number of subjects: 80
Study: 1812903

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine solution (1 mL) irrigation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Physiological saline or no irrigation (control)
Number of subjects: 12
Study: 6682323

Group type: EXPERIMENTAL
Intervention: 2 mg carteolol p.o.
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 1, 2, 5 or 25 mg carteolol
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.5 mg carteolol
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 5 to 25 mg carteolol
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: carteolol
Number of subjects: 28
Study: 30872010

Group type: EXPERIMENTAL
Intervention: MARQUE intervention
Number of subjects: 404

Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 404
Study: 29059510

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE) at 80% V˙O2 R
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Exercise (MIE) at 50% V˙O2 R
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-Intensity Exercise (LIE) at 35% V˙O2 R
Number of subjects: 10

Group type: COMPARATOR
Intervention: No-exercise control
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-Intensity Exercise (LIE)
Number of subjects: 10
Study: 26907584

Group type: EXPERIMENTAL
Intervention: eHealth diary and symptom-tracking tool combined with person-centered care (PCC)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: PCC without eHealth tool
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 199
Study: 24923300

Group type: EXPERIMENTAL
Intervention: WHO Package of CV risk assessment, patient education, initiation and titration of antihypertensive medications, behavioral counseling on lifestyle behaviors, and medication adherence every three months for 12 months.
Number of subjects: 640
Study: 22172088

Group type: EXPERIMENTAL
Intervention: New logical memory stories
Number of subjects: 240

Group type: COMPARATOR
Intervention: Traditional Wechsler Memory Scales stories
Number of subjects: 240
Study: 19653548

Group type: EXPERIMENTAL
Intervention: Univariate linear regression models
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Change in response or exit score as a function of baseline response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Model including baseline response as covariate
Number of subjects: 0
Study: 18760122

Group type: EXPERIMENTAL
Intervention: Early surgery strategy (surgical procedure performed within 48 hours of randomization)
Number of subjects: 216

Group type: COMPARATOR
Intervention: State-of-the-art therapeutic strategy (advised by international societies in their guidelines)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Follow-up substudy
Number of subjects: 216
Study: 15703368

Group type: EXPERIMENTAL
Intervention: High-dose oxymorphone ER (3 x 20 mg q12h) + naltrexone (50 mg q24h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose oxymorphone ER (10-20 mg q12h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rifampin (2 x 300 mg q24h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg q24h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CYP probes alone (controls)
Number of subjects: 0
Study: 12369078

Group type: EXPERIMENTAL
Intervention: Treatment for acute myocardial infarction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 10064246

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg/d for 12 months)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Fluconazole (200 mg/d for 12 months)
Number of subjects: 108
Study: 8613283

Group type: EXPERIMENTAL
Intervention: UV lamp method for assessing compliance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Torch light method for assessing compliance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison of UV lamp and torch light methods
Number of subjects: 0
Study: 2188312

Group type: EXPERIMENTAL
Intervention: Alternating air (AA) mattress overlay
Number of subjects: 187

Group type: COMPARATOR
Intervention: Silicore (S) mattress overlay
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Both overlays (AA and S)
Number of subjects: 187
Study: 6105519

Group type: EXPERIMENTAL
Intervention: Prednisone 20 mg daily
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Azathioprine 100 mg daily
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Prednisone 20 mg and azathioprine 50 mg daily
Number of subjects: 101

Group type: COMPARATOR
Intervention: B vitamins 2 tablets daily
Number of subjects: 101
Study: 30997140

Group type: EXPERIMENTAL
Intervention: Dual red imaging (DRI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: White light imaging (WLI)
Number of subjects: 0
Study: 29691625

Group type: EXPERIMENTAL
Intervention: Minimally invasive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 8
Study: 27598452

Group type: EXPERIMENTAL
Intervention: Pulley suture technique
Number of subjects: 21

Group type: COMPARATOR
Intervention: Bilayered closure
Number of subjects: 21
Study: 24768658

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Cardiovascular Health Training Classroom (CHTC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control Group (CG) - No specific intervention mentioned
Number of subjects: 150
Study: 21987667

Group type: EXPERIMENTAL
Intervention: Minimal extracorporeal circulation system (MECC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional CPB
Number of subjects: 40
Study: 20181334

Group type: EXPERIMENTAL
Intervention: Written educational material provided to the case group
Number of subjects: 140

Group type: COMPARATOR
Intervention: Brief information about pre-endoscopy preparation (control group)
Number of subjects: 140
Study: 17828096

Group type: EXPERIMENTAL
Intervention: Perftorane
Number of subjects: 76
Study: 15386757

Group type: EXPERIMENTAL
Intervention: 19‐min video developed for this study
Number of subjects: 79

Group type: COMPARATOR
Intervention: Written pamphlet control condition
Number of subjects: 79
Study: 12091194

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with lithium and adjunctive psychotherapy specific to bipolar disorder
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacotherapy with lithium and nonspecific intensive clinical management
Number of subjects: 0
Study: 10484310

Group type: EXPERIMENTAL
Intervention: Preoperative preparatory program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no preparatory program)
Number of subjects: 0
Study: 8942490

Group type: EXPERIMENTAL
Intervention: Standard-dose triptorelin for 8 weeks followed by reduced-dose triptorelin (100, 20, or 5 micrograms) until week 26
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Reduced-dose triptorelin (100, 20, or 5 micrograms)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: High-dose triptorelin
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Reduced-dose triptorelin
Number of subjects: 27
Study: 1959366

Group type: EXPERIMENTAL
Intervention: Pharmacokinetic dosing of aminoglycosides
Number of subjects: 95

Group type: COMPARATOR
Intervention: Traditional physician-directed techniques
Number of subjects: 95
Study: 6181452

Group type: EXPERIMENTAL
Intervention: Single session argon laser photocoagulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiple sessions of argon laser photocoagulation
Number of subjects: 0
Study: 29482614

Group type: EXPERIMENTAL
Intervention: TAU+app
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: TAU+app+alarms
Number of subjects: 150

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 150
Study: 26830676

Group type: EXPERIMENTAL
Intervention: Telephone simulation training (4 sessions over 6-8 months)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Telephone simulation training
Number of subjects: 160
Study: 25193506

Group type: EXPERIMENTAL
Intervention: 150 mg/day ranitidine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 300 mg/day ranitidine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 75
Study: 23583763

Group type: EXPERIMENTAL
Intervention: Enalapril and carvedilol (n = 45)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (n = 45)
Number of subjects: 90
Study: 20874458

Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol (MF/F) 200/10 μg
Number of subjects: 404

Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol (FP/S) 250/50 μg
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol (MF/F) 400/10 μg
Number of subjects: 404

Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol (FP/S) 500/50 μg
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol (MF/F)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol (FP/S)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Both MF/F and FP/S
Number of subjects: 404
Study: 18688066

Group type: EXPERIMENTAL
Intervention: Double-dose sirolimus-eluting stents (SES) (280 microg/cm2)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Single-dose sirolimus-eluting stents (SES) (140 microg/cm2)
Number of subjects: 39
Study: 16377679

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 200

Group type: COMPARATOR
Intervention: Caspofungin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 14733381

Group type: EXPERIMENTAL
Intervention: Pamphlet with a brief educational message and a 2-minute scripted overview
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no pamphlet)
Number of subjects: 103
Study: 10807457

Group type: COMPARATOR
Intervention: Troponin T
Number of subjects: 447

Group type: COMPARATOR
Intervention: C-reactive protein (CRP)
Number of subjects: 447
Study: 8813924

Group type: EXPERIMENTAL
Intervention: Sildenafil 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1311660

Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 17
Study: 4082876

Group type: EXPERIMENTAL
Intervention: 70% isopropyl alcohol as a skin disinfectant
Number of subjects: 187

Group type: COMPARATOR
Intervention: No skin disinfectant
Number of subjects: 187
Study: 31325313

Group type: EXPERIMENTAL
Intervention: PCT-guided treatment
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard care respiratory control
Number of subjects: 119
Study: 29807859

Group type: EXPERIMENTAL
Intervention: Ultraviolet air sterilizer (UVAS)
Number of subjects: 1097
Study: 26674372

Group type: EXPERIMENTAL
Intervention: 50 mg naltrexone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 25775393

Group type: COMPARATOR
Intervention: Positive expression of CDC25B protein (48.5%)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Positive expression of PED/PEA‐15 protein (68.2%)
Number of subjects: 66

Group type: COMPARATOR
Intervention: PED/PEA‐15 positive expression group
Number of subjects: 66
Study: 23469602

Group type: EXPERIMENTAL
Intervention: Lidan Mixture (LM) combined with ganciclovir
Number of subjects: 240

Group type: COMPARATOR
Intervention: Ganciclovir alone
Number of subjects: 240
Study: 20210619

Group type: EXPERIMENTAL
Intervention: S1: Cold water immersion (2 degrees C) until T(re) reached 37.5 degrees C
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: S2: Recovery in a temperate environment (30 degrees C, 30% relative humidity) for 60 minutes
Number of subjects: 24
Study: 18586126

Group type: EXPERIMENTAL
Intervention: Bilateral training
Number of subjects: 106

Group type: COMPARATOR
Intervention: Unilateral training
Number of subjects: 106
Study: 15707912

Group type: EXPERIMENTAL
Intervention: True enactment of verbal material
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study: 11817465

Group type: EXPERIMENTAL
Intervention: Opalescence products (10%, 15%, 20%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nite White products (10%, 16%, 22%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rembrandt products (10%, 15%, 22%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trays with reservoirs (Opalescence)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trays without reservoirs
Number of subjects: 0
Study: 9973007

Group type: EXPERIMENTAL
Intervention: 0.25 mg digoxin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 240 mg diltiazem‐CD
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 mg atenolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.25 mg digoxin + 240 mg diltiazem‐CD
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.25 mg digoxin + 50 mg atenolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: digoxin + atenolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: regimens including atenolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: digoxin and digoxin + atenolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: all treatment groups
Number of subjects: 12